{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:05:46Z","timestamp":1784783146102,"version":"3.55.0"},"reference-count":86,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babes University of Medicine and Pharmacy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Parsonage\u2013Turner syndrome (PTS) is an inflammatory condition of the brachial plexus, with more than half of patients presenting a trigger, such as infection or vaccination. Our objective was to synthesize the clinical and paraclinical features, therapeutic responses, and outcomes of PTS post-COVID-19 vaccination. Methods: We systematically reviewed two databases (LitCOVID and the WHO database on COVID-19) up to January 2024 following a published protocol (OSF registries). Results: We included 59 cases. PTS occurred more frequently in males (61.1% mRNA group, 83.3% viral vector group). Patients in the mRNA group were younger (41.7% between 41 and 50 years vs. 38.9% between 61 and 70 years). Most cases had sudden pain within two weeks. Unilateral PTS was present in 94.4% of mRNA and all viral vector-vaccinated cases. Symptoms included pain (97.1% and 92.3%, respectively), usually followed within two weeks by motor deficits (97.2% and 94.1%, respectively), amyotrophy (30% and 81.8%, respectively), paresthesia (50% and 27.3%, respectively), and sensory loss (33.3% and 38.5%, respectively). Viral vector vaccine recipients had nerve involvement outside the brachial plexus. Ancillary investigations revealed CSF albuminocytological dissociation (33.3% and 100%, respectively) and ipsilateral axillary lymphadenopathy. Two PTS cases worsened after the second mRNA dose, and another recurred after influenza vaccination. One patient well tolerated the second dose of the viral vector vaccine, but symptoms reemerged in another. Conclusions: Current evidence suggests PTS may occur after all COVID-19 vaccine types, with some subgroup differences. Also, PTS might recur with subsequent similar or unrelated vaccines.<\/jats:p>","DOI":"10.3390\/vaccines12030306","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:32:30Z","timestamp":1710495150000},"page":"306","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Parsonage\u2013Turner Syndrome following COVID-19 Vaccination: A Systematic Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-1942","authenticated-orcid":false,"given":"Elena Cecilia","family":"Rosca","sequence":"first","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3147-5060","authenticated-orcid":false,"given":"Almonzer","family":"Al-Qiami","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Science, University of Kassala, Kassala 1115, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-3414","authenticated-orcid":false,"given":"Amalia","family":"Cornea","sequence":"additional","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Simu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/brain\/awh722","article-title":"The clinical spectrum of neuralgic amyotrophy in 246 cases","volume":"129","year":"2006","journal-title":"Brain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(48)90611-4","article-title":"Neuralgic amyotrophy; the shoulder-girdle syndrome","volume":"1","author":"Parsonage","year":"1948","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.410180308","article-title":"Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970\u20131981","volume":"18","author":"Beghi","year":"1985","journal-title":"Ann. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"van Alfen, N., van Eijk, J.J., Ennik, T., Flynn, S.O., Nobacht, I.E., Groothuis, J.T., Pillen, S., and van de Laar, F.A. (2015). Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128361"},{"key":"ref_5","unstructured":"Ferrante, M.A. (2023, February 01). Neuralgic Amyotrophy. Available online: https:\/\/www.medlink.com\/articles\/neuralgic-amyotrophy."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jbspin.2016.03.005","article-title":"Neuralgic amyotrophy. An update","volume":"84","author":"Seror","year":"2017","journal-title":"Jt. Bone Spine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mus.25008","article-title":"Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment","volume":"53","author":"Groothuis","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1002\/mus.26454","article-title":"Nivolumab-induced neuralgic amyotrophy with hourglass-like constriction of the anterior interosseous nerve","volume":"59","author":"Porambo","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mdc3.12710","article-title":"Brachial Neuritis after Botulinum Toxin Injections for Cervical Dystonia: A Need for a Reappraisal?","volume":"6","author":"Cani","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mus.880130807","article-title":"Neuralgic amyotrophy with involvement of cranial nerves IX, X, XI and XII","volume":"13","author":"Pierre","year":"1990","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0404.1991.tb04674.x","article-title":"Blood lymphocytes are sensitized to branchial plexus nerves in patients with neuralgic amyotrophy","volume":"83","author":"Sierra","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archneur.1993.00540120016006","article-title":"Anti-peripheral nerve myelin antibodies and terminal activation products of complement in serum of patients with acute brachial plexus neuropathy","volume":"50","author":"Vriesendorp","year":"1993","journal-title":"Arch. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/WNL.46.2.559","article-title":"Immune brachial plexus neuropathy: Suggestive evidence for an inflammatory-immune pathogenesis","volume":"46","author":"Suarez","year":"1996","journal-title":"Neurology"},{"key":"ref_14","unstructured":"WHO (2022, September 08). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Peters, M., Godfrey, C., McInerney, P., Munn, Z., Tricco, A., and Khalil, H. (2024, March 02). Chapter 11: Scoping Reviews (2020 Version). Available online: https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL\/4687342\/Chapter+11%3A+Scoping+reviews.","DOI":"10.46658\/JBIRM-20-01"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.11124\/JBIES-21-00242","article-title":"Best practice guidance and reporting items for the development of scoping review protocols","volume":"20","author":"Peters","year":"2022","journal-title":"JBI Evid. Synth."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid.-Based Med."},{"key":"ref_19","unstructured":"WHO (2023, September 09). The Use of the WHO-UMC System for Standardised Case Causality Assessment. Available online: https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment."},{"key":"ref_20","unstructured":"WHO (2019). Causality Assessment of an Adverse Event Following Immunization (AEFI): User Manual for the Revised WHO Classification Second Edition, 2019 Update, World Health Organization."},{"key":"ref_21","unstructured":"Brighton Collaboration (2024, February 07). Case Definitions. Available online: https:\/\/brightoncollaboration.org\/case-definitions\/."},{"key":"ref_22","first-page":"e25493","article-title":"COVID-19 Vaccine-Induced Parsonage-Turner Syndrome: A Case Report and Literature Review","volume":"14","author":"Amjad","year":"2022","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurol.2021.11.004","article-title":"COVID-19: A putative trigger for neuralgic amyotrophy","volume":"178","author":"Balloy","year":"2022","journal-title":"Rev. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/CND.0000000000000411","article-title":"Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine","volume":"23","author":"Bernheimer","year":"2022","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.25259\/SNI_4_2022","article-title":"Parsonage-Turner syndrome following COVID-19 vaccination and review of the literature","volume":"13","author":"Chua","year":"2022","journal-title":"Surg. Neurol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1007\/s10072-022-06004-z","article-title":"Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination","volume":"43","author":"Civardi","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e21.00370","DOI":"10.2106\/JBJS.CC.21.00370","article-title":"Parsonage-Turner Syndrome after SARS-CoV-2 BNT162b2 Vaccine: A Case Report","volume":"11","author":"Coffman","year":"2021","journal-title":"JBJS Case Connect."},{"key":"ref_28","first-page":"571","article-title":"Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine","volume":"36","year":"2021","journal-title":"Neurologia (Engl. Ed.)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/pmrj.12619","article-title":"Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report","volume":"14","author":"Edmond","year":"2022","journal-title":"PM R"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e21.00577","DOI":"10.2106\/JBJS.CC.21.00577","article-title":"Parsonage-Turner Syndrome after COVID-19 Vaccination: A Case Report","volume":"11","author":"Flikkema","year":"2021","journal-title":"JBJS Case Connect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CND.0000000000000396","article-title":"Neuralgic Amyotrophy after ChAdOx1 nCoV-19 COVID-19 Vaccination","volume":"24","author":"James","year":"2022","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.3346\/jkms.2022.37.e283","article-title":"Diaphragmatic Dysfunction due to Neuralgic Amyotrophy after SARS-CoV-2 Vaccination: A Case Report","volume":"37","author":"Kang","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3000605211056783","DOI":"10.1177\/03000605211056783","article-title":"Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: A case report","volume":"49","author":"Kim","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/qjmed\/hcab216","article-title":"Neuralgic amyotrophy following COVID-19 mRNA vaccination","volume":"114","author":"Koh","year":"2021","journal-title":"QJM"},{"key":"ref_35","first-page":"e27867","article-title":"Parsonage-Turner Syndrome Following Covishield (AstraZeneca ChAdOx1 nCoV-19) Vaccination: A Case Report","volume":"14","author":"Lakkireddy","year":"2022","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13760-022-01941-0","article-title":"Neuromuscular complications after COVID-19 vaccination: A series of eight patients","volume":"122","author":"Leemans","year":"2022","journal-title":"Acta Neurol. Belg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1002\/mus.27255","article-title":"Parsonage Turner syndrome after COVID-19 vaccination","volume":"64","author":"Mahajan","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e6483","DOI":"10.1002\/ccr3.6483","article-title":"Parsonage-Turner syndrome of the brachial plexus secondary to COVID-19 vaccine: A case report","volume":"10","author":"Mejri","year":"2022","journal-title":"Clin. Case Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/jnnp-2021-328182","article-title":"Parsonage-Turner syndrome following COVID-19 vaccination","volume":"93","author":"Min","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5606\/tftrd.2022.10456","article-title":"Parsonage-Turner syndrome after SARS-CoV-2 vaccination: A case report","volume":"68","author":"Oncel","year":"2022","journal-title":"Turk. J. Phys. Med. Rehabil."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1148\/radiol.2021211374","article-title":"Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography","volume":"302","author":"Queler","year":"2021","journal-title":"Radiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4103\/aian.aian_354_22","article-title":"Parsonage-Turner Syndrome Following COVID-19 Vaccine","volume":"25","author":"Sharma","year":"2022","journal-title":"Ann. Indian. Acad. Neurol."},{"key":"ref_43","first-page":"e21244","article-title":"A Rare Case of Brachial Plexus Neuropraxia after COVID-19 Vaccination","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s13256-021-03176-8","article-title":"Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: A case report and review of the literature","volume":"15","author":"Vitturi","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_45","first-page":"e22","article-title":"Parsonage-Turner Syndrome after COVID-19 Vaccination in a Child","volume":"7","author":"Cassart","year":"2023","journal-title":"J. Am. Acad. Orthop. Surg. Glob. Res. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2022.11.014","article-title":"Neuralgic Amyotrophy after COVID-19 Vaccination in an Adolescent: Successful Intravenous Immunoglobulin Treatment","volume":"140","author":"Fukahori","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"ref_47","first-page":"003779","article-title":"Winged Scapula Caused by Parsonage-Turner Syndrome after Bnt162b2 Mrna COVID-19 Vaccination","volume":"10","author":"Ishizuka","year":"2023","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_48","first-page":"e45040","article-title":"Brachial Neuritis after a COVID-19 Booster Vaccination: A Case Report and Literature Review","volume":"15","author":"Loganathan","year":"2023","journal-title":"Cureus"},{"key":"ref_49","first-page":"e34710","article-title":"Parsonage-Turner Syndrome Post-COVID-19 Oxford\/AstraZeneca Vaccine Inoculation: A Case Report and Brief Literature Review","volume":"15","author":"Meixedo","year":"2023","journal-title":"Cureus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000521462","article-title":"Parsonage-Turner Syndrome Following COVID-19 Vaccination: Clinical and Electromyographic Findings in 6 Patients","volume":"14","author":"Shields","year":"2022","journal-title":"Case Rep. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.51866\/cr.184","article-title":"Parsonage-Turner syndrome: A case report of a rare side effect of COVID-19 booster vaccination","volume":"18","author":"Yeoh","year":"2023","journal-title":"Malays. Fam. Physician"},{"key":"ref_52","first-page":"S7","article-title":"Torsional Neuropathy in Parsonage Turner Syndrome following anti-COVID-19 vaccination. How to detect and manage with it?","volume":"27","author":"Cabona","year":"2022","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_53","first-page":"S169","article-title":"More Than a Sore Shoulder Post COVID Shot: A Case of Parsonage Turner Syndrome Following COVID-19 Vaccination","volume":"14","author":"Cascio","year":"2022","journal-title":"PM R"},{"key":"ref_54","first-page":"S166","article-title":"Guillain-Barre Syndrome and Parsonage-Turner Syndrome Following COVID-19 Viral Vector Vaccination","volume":"14","author":"Dovgan","year":"2022","journal-title":"PM R"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s40278-022-12466-6","article-title":"COVID-19-vaccine: Parsonage-Turner Syndrome: Case report","volume":"1900","author":"Igbokwe","year":"2022","journal-title":"React. Wkly."},{"key":"ref_56","first-page":"S170","article-title":"Parsonage Turner Syndrome after COVID-19 Vaccine Booster: A Case Report and Review of the Literature","volume":"14","author":"Koduri","year":"2022","journal-title":"PM R"},{"key":"ref_57","first-page":"S21","article-title":"A Complex Clinical Presentation of Cervical Radiculopathy with Concurrent Parsonage Turner Syndrome: A Case Report","volume":"14","author":"Pham","year":"2022","journal-title":"PM R"},{"key":"ref_58","first-page":"S1","article-title":"2021 AAPM&R Annual Assembly Abstracts","volume":"13","author":"Pilgram","year":"2021","journal-title":"PM R"},{"key":"ref_59","first-page":"S162","article-title":"Parsonage-Turner Syndrome after COVID-19 Vaccination","volume":"9","author":"Dorban","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.anai.2022.08.773","article-title":"Brachial Neuritis from the Mrna Sars-Cov-2 and Influenza Vaccines","volume":"129","author":"VanLancker","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_61","first-page":"S171","article-title":"Parsonage-Turner Syndrome Resulting in Spinal Accessory Nerve Lesion after COVID-19 Vaccine: A Case Report","volume":"14","author":"Chen","year":"2022","journal-title":"PM R"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Cornea, A., Lata, I., Simu, M., and Rosca, E.C. (2023). Parsonage-Turner Syndrome Following SARS-CoV-2 Infection: A Systematic Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030837"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mus.25422","article-title":"Lesion distribution among 281 patients with sporadic neuralgic amyotrophy","volume":"55","author":"Ferrante","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00415-006-0246-4","article-title":"The neuralgic amyotrophy consultation","volume":"254","year":"2007","journal-title":"J. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1212\/01.wnl.0000216140.25497.40","article-title":"Phrenic neuropathy due to neuralgic amyotrophy","volume":"66","author":"Tsao","year":"2006","journal-title":"Neurology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1529-8027.2002.02025.x","article-title":"Neuralgic amyotrophy: Variable expression in 40 patients","volume":"7","author":"Barrio","year":"2002","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/cyt.13221","article-title":"COVID-19 post-vaccination lymphadenopathy: A review of the use of fine needle aspiration cytology","volume":"34","author":"Caputo","year":"2023","journal-title":"Cytopathology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/jmv.27599","article-title":"Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review","volume":"94","author":"Bshesh","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Treglia, G., Cuzzocrea, M., Giovanella, L., Elzi, L., and Muoio, B. (2021). Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[(18)F]FDG PET\/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080762"},{"key":"ref_70","first-page":"199","article-title":"BCG-induced axillary lymph-adenitis in the adult","volume":"119","author":"Newfield","year":"1990","journal-title":"Harefuah"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.28.9.1194","article-title":"Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination","volume":"28","author":"Studdiford","year":"2008","journal-title":"Pharmacotherapy"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12149-011-0568-x","article-title":"Axillary lymph node accumulation on FDG-PET\/CT after influenza vaccination","volume":"26","author":"Shirone","year":"2012","journal-title":"Ann. Nucl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mus.24615","article-title":"Ultrasonographic identification of nerve pathology in neuralgic amyotrophy: Enlargement, constriction, fascicular entwinement, and torsion","volume":"52","author":"Csillik","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mus.25708","article-title":"Ultrasonography in neuralgic amyotrophy: Sensitivity, spectrum of findings, and clinical correlations","volume":"56","author":"Csillik","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mus.26108","article-title":"Brachial plexitis or neuritis? MRI features of lesion distribution in Parsonage-Turner syndrome","volume":"58","author":"Sneag","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.26322","article-title":"Ultrasound of peripheral nerves in neuralgic amyotrophy","volume":"59","author":"Pillen","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2011.11.020","article-title":"MR imaging of peripheral nervous system involvement: Parsonage-Turner syndrome","volume":"315","author":"Zara","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/01616412.2022.2138038","article-title":"Neuralgic amyotrophy detected by magnetic resonance neurography: Subclinical, bilateral, and multifocal brachial plexus involvement","volume":"45","author":"Cejas","year":"2023","journal-title":"Neurol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mus.27732","article-title":"Imaging of neuralgic amyotrophy in the acute phase","volume":"66","author":"Ripellino","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/ijri.IJRI_269_19","article-title":"MR neurography in Parsonage-Turner syndrome","volume":"29","author":"Upadhyaya","year":"2019","journal-title":"Indian J. Radiol. Imaging"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_82","unstructured":"CIOMS\/WHO (2024, February 07). Definition and Application of Terms for Vaccine Pharmacovigilance. Report of CIOMS\/WHO Working Group on Vaccine Pharmacovigilance. Available online: https:\/\/www.who.int\/publications\/m\/item\/9789290360834."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"k3948","DOI":"10.1136\/bmj.k3948","article-title":"Pandemrix vaccine: Why was the public not told of early warning signs?","volume":"362","author":"Doshi","year":"2018","journal-title":"BMJ"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/mus.27734","article-title":"Associations of neuralgic amyotrophy with COVID-19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database","volume":"66","author":"Kim","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","article-title":"VigiBase, the WHO Global ICSR Database System: Basic Facts","volume":"42","author":"Lindquist","year":"2008","journal-title":"Drug Inf. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.therap.2023.03.005","article-title":"Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)","volume":"78","author":"Tebacher","year":"2023","journal-title":"Therapie"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/3\/306\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:13:31Z","timestamp":1760105611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/3\/306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["vaccines12030306"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12030306","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}